Mint Explainer | India's big bet: ₹5,000 crore to transform pharma R&D. See what it means.
India’s ₹5,000-cr plan opens applications to fund pharma and medtech R&D, helping firms move beyond low-cost generics toward new drugs, complex therapies, and global innovation.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
